HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutaneous Rosai-Dorfman disease: histopathological presentation as inflammatory pseudotumor. A literature review.

Abstract
Purely cutaneous Rosai-Dorfman disease is exceptional. The disease is characterized histologically by large, proliferating histiocytes exhibiting inflammatory cells within their cytoplasm (emperipolesis). We present here a case of purely cutaneous generalized disease in which the routine histopathology was suggestive of an inflammatory pseudotumor. Positivity for S-100 protein, alpha1-antitrypsin, alpha1-antichymotrypsin, lysozyme, Mac387 and CD68 proteins, and negativity for CD1a protein confirmed the diagnosis of Rosai-Dorfman disease. The rarity of this case lies in the presence of conspicuous inflammatory pseudotumor-like histopathologic changes, masking an otherwise typical sinus histiocytosis cell infiltrate. This unusual presentation of the disease requires a high index of suspicion by clinicians and pathologists.
AuthorsGeorge Kroumpouzos, Marie-France Demierre
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 82 Issue 4 Pg. 292-6 ( 2002) ISSN: 0001-5555 [Print] Sweden
PMID12361136 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antigens, CD
  • Antigens, CD1
  • Antigens, Differentiation, Myelomonocytic
  • CD1a antigen
  • CD68 antigen, human
  • S100 Proteins
  • alpha 1-Antichymotrypsin
  • alpha 1-Antitrypsin
  • Muramidase
Topics
  • Adult
  • Antigens, CD (analysis)
  • Antigens, CD1 (analysis)
  • Antigens, Differentiation, Myelomonocytic (analysis)
  • Diagnosis, Differential
  • Female
  • Granuloma, Plasma Cell (pathology)
  • Histiocytosis, Sinus (pathology)
  • Humans
  • Immunohistochemistry
  • Muramidase (analysis)
  • S100 Proteins (analysis)
  • Skin Diseases (pathology)
  • alpha 1-Antichymotrypsin (analysis)
  • alpha 1-Antitrypsin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: